CGMP-specific phosphodiesterase type 5

PDE5A
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesPDE5A, CGB-PDE, CN5A, PDE5, phosphodiesterase 5A
External IDsOMIM: 603310; MGI: 2651499; HomoloGene: 842; GeneCards: PDE5A; OMA:PDE5A - orthologs
EC number3.1.4.35
Orthologs
SpeciesHumanMouse
Entrez

8654

242202

Ensembl

ENSG00000138735

ENSMUSG00000053965

UniProt

O76074

Q8CG03

RefSeq (mRNA)

NM_033437
NM_001083
NM_033430

NM_153422

RefSeq (protein)

NP_001074
NP_236914
NP_246273

NP_700471

Location (UCSC)Chr 4: 119.49 – 119.63 MbChr 3: 122.52 – 122.65 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Cyclic guanosine monophosphate-specific phosphodiesterase type 5 is an enzyme (EC 3.1.4.17) from the phosphodiesterase class. It is found in various tissues, most prominently the corpus cavernosum of the clitoris and of the penis as well as the retina. It has also been recently discovered to play a vital role in the cardiovascular system.

The phosphodiesterase (PDE) isozymes, found in several tissues including the rod and cone photoreceptor cells of the retina, belong to a large family of cyclic nucleotide PDEs that catalyze cAMP and cGMP hydrolysis.

The interest in PDEs as molecular targets of drug action has grown with the development of isozyme-selective PDE inhibitors that offer potent inhibition of selected isozymes without the side-effects attributed to nonselective inhibitors such as theophylline.

Sildenafil, vardenafil, tadalafil, and avanafil are PDE5 inhibitors that are significantly more potent and selective than zaprinast and other early PDE5 inhibitors.